Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
2,901	31.45499	1	female	0	7	198	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	under $11k	0	12,363	8,496.1641	6,908.94922	7.5	black	26.796875	38	0.868896	0.822998	1	1	0	no	0.6	0.5	no dnr	7	131	11	103	10	37.69531	96	3	1.299805	2.699707	144	7.429688	392	53	924	null	null	adl>=4 (>=5 if sur)	2.064941
2,902	35.60797	0	female	0	19	685	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	>$50k	0	55,312	30,751.875	35,774.4062	23	white	20.5	24	0.912964	0.880981	1	0	0	no	1	0.95	no dnr	19	139	null	106	28	35.59375	219.03125	3.299805	0.5	8.398438	137	7.449219	92	53	325	null	0	no(M2 and SIP pres)	0
2,903	76.18896	0	female	0	3	685	COPD	COPD/CHF/Cirrhosis	4	null	null	0	4,601	2,396.1289	2,195.38867	null	white	13	8	0.856934	0.763916	1	0	1	yes	null	null	dnr before sadm	-1	65	12.5	60	30	37.69531	126.51562	3.099609	null	1.5	140	7.429688	210	52	800	null	null	null	4.192383
2,904	83.07495	1	female	0	17	29	Coma	Coma	1	14	$11-$25k	37	25,394	15,203.2812	15,030.9531	13.666664	white	17.097656	18	0.371948	0.297974	1	0	0	metastatic	0.5	0.2	dnr before sadm	-1	38	39.398438	52	14	38.69531	354	2.799805	0.399963	7.799805	130	7.329102	63	63	0	null	2	<2 mo. follow-up	2
2,905	81.00995	1	male	0	10	16	Lung Cancer	Cancer	1	16	null	0	12,735	6,927.9883	7,069.69922	14	white	16	24	0.690918	0.399963	1	0	0	metastatic	0.1	0	dnr after sadm	2	72	10.599609	103	12	36.39844	241.65625	2.699707	0.399963	0.699951	143	7.40918	292	26	1,375	null	3	<2 mo. follow-up	3
2,906	52.11798	0	male	0	37	682	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	141,717	95,230	80,719.75	39	black	24.097656	43	0.824951	0.765991	3	1	0	no	0.3	0.3	no dnr	37	53	6.5	60	24	36.59375	161.21875	2.799805	null	0.699951	135	7.469727	99	7	1,275	null	null	null	2.054688
2,907	89.547	1	female	0	12	141	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	16,186	8,523.2422	8,228.25781	15.5	white	21.597656	42	0.746948	0.600952	1	0	0	no	0.6	0.5	no dnr	12	75	14	74	24	35.89844	276.1875	null	null	1.5	136	7.449219	106	22	3,750	1	3	adl>=4 (>=5 if sur)	3
2,908	90.03094	1	male	0	14	32	CHF	COPD/CHF/Cirrhosis	3	null	>$50k	0	19,286	9,880.3359	10,211.0078	7	white	17.597656	23	0.80896	0.690918	1	0	0	no	0.7	0.6	dnr after sadm	6	83	11.298828	100	20	35.39844	null	2.099609	3.699707	0.899902	131	null	96	11	750	0	0	<2 mo. follow-up	0
2,909	78.00696	1	female	0	9	212	Colon Cancer	Cancer	2	8	$11-$25k	0	9,633	5,673.2227	5,506.94922	13.5	white	28.699219	10	0.545898	0.222992	1	0	0	metastatic	0.9	0.9	no dnr	9	57	11.699219	70	10	38.19531	176	2.299805	0.5	2.699707	132	7.359375	141	63	2,170	1	1	no(M2 and SIP pres)	1
2,910	74.771	1	female	1	29	29	ARF/MOSF w/Sepsis	ARF/MOSF	4	14	$25-$50k	0	144,316	96,597.3125	80,722.375	39.5	hispanic	33.796875	52	0.482971	0.363953	1	0	0	yes	0.3	0.2	dnr after sadm	15	54	117	118	30	38.19531	null	null	null	0.5	137	7.429688	105	23	930	null	0	<2 mo. follow-up	0
2,911	79.82794	0	female	0	10	680	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	null	0	16,884	9,903.6406	9,306.90625	16	white	19.898438	33	0.814941	0.753906	1	0	0	no	0.95	0.9	no dnr	10	57	8.798828	60	20	38.29688	141.65625	3	1	1.199951	137	7.379883	129	17	4,600	0	null	no(M2 and SIP pres)	0.494751
2,912	48.55899	0	male	0	4	680	CHF	COPD/CHF/Cirrhosis	4	14	$25-$50k	0	4,980	2,690.5996	3,391.92969	9	white	18.199219	17	0.891968	0.819946	1	0	0	yes	null	null	no dnr	4	100	3.699707	60	25	36.09375	null	null	null	2.799805	143	null	89	70	1,600	null	null	no(M2 and SIP pres)	2.184082
2,913	68.65399	1	male	0	38	158	ARF/MOSF w/Sepsis	ARF/MOSF	2	15	null	0	98,707	null	null	34.5	black	27.398438	32	0.737915	0.655884	1	1	0	no	0.9	0.7	no dnr	38	60	10	110	12	38.5	180	2.299805	0.599976	2.199707	148	7.359375	106	46	2,044	null	0	adl>=4 (>=5 if sur)	0
2,914	20.05199	0	female	0	13	678	Cirrhosis	COPD/CHF/Cirrhosis	1	13	under $11k	0	27,570	16,774.4219	15,263.875	11.5	asian	28.597656	37	0.866943	0.779907	1	0	0	no	0.6	0.5	no dnr	13	82	17	120	30	38.09375	135	null	null	1	137	7.449219	373	30	1,500	0	0	null	0
2,915	51.86298	0	male	0	49	677	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	193,178	116,287.625	102,016.438	48	white	33.695313	62	0.612915	0.506958	11	0	0	no	0.2	0.1	no dnr	49	63	4.799805	38	26	36.19531	null	null	0.699951	1.899902	140	null	98	78	1,890	null	0	no(M2 and SIP pres)	0
2,916	85.85895	0	male	0	10	677	COPD	COPD/CHF/Cirrhosis	2	10	under $11k	0	14,731	8,202.5156	7,041.92969	16.5	white	20.796875	24	0.726929	0.573975	1	0	1	no	null	null	dnr after sadm	1	73	2.599609	180	4	36.59375	140	2.299805	4.399414	2.699707	136	7.359375	97	49	750	null	7	adl>=4 (>=5 if sur)	7
2,917	72.24597	1	female	0	7	27	Lung Cancer	Cancer	4	12	$11-$25k	0	10,505	5,559.7383	5,308.29688	7	white	20.296875	41	0.615967	0.301941	1	1	0	metastatic	0.8	0.6	no dnr	7	77	8.199219	73	8	37.69531	165	null	null	1	140	7.429688	102	22	4,000	0	0	<2 mo. follow-up	0
2,918	70.26996	1	female	0	16	259	CHF	COPD/CHF/Cirrhosis	4	12	$25-$50k	0	15,786	9,205.1953	8,086.22656	12	white	21	26	0.792969	0.667969	1	1	0	yes	0.6	0.5	dnr after sadm	5	131	13.099609	120	7	38	240.8125	null	0.599976	2.5	143	7.269531	114	52	399	2	0	null	0
2,919	74.87195	1	female	0	4	5	Lung Cancer	Cancer	1	12	null	0	4,868	2,726.8789	2,120.68945	7	white	15.398438	14	0.715942	0.436951	1	0	0	metastatic	null	null	dnr after sadm	1	112	10.699219	118	40	39.19531	266.625	2.399902	1.799805	1.699951	141	7.459961	144	14	3,100	null	null	<2 mo. follow-up	2.908691
2,920	59.65198	0	male	0	17	675	ARF/MOSF w/Sepsis	ARF/MOSF	4	10	$11-$25k	0	70,523	37,017.0938	33,704.9688	34.333313	white	22	29	0.829956	0.771973	3	1	0	no	null	null	no dnr	17	123	9.099609	80	20	37.59375	433.3125	3.299805	0.899902	5.199219	122	7.289062	943	64	null	null	null	no(M2 and SIP pres)	2.557129
2,921	66.34595	0	female	0	11	675	COPD	COPD/CHF/Cirrhosis	3	14	>$50k	0	12,506	6,952.1836	8,685.125	11.5	white	13.898438	27	0.887939	0.812988	1	0	0	yes	1	1	no dnr	11	108	7.5	114	8	38.39844	185	3	null	0.599976	139	7.40918	75	9	4,895	1	2	no(M2 and SIP pres)	2
2,922	58.60898	1	female	0	24	674	COPD	COPD/CHF/Cirrhosis	4	12	$11-$25k	0	76,228	58,941.125	48,895	30	white	38.796875	49	0.584961	0.391968	1	0	0	no	0.7	0.6	no dnr	24	83	14.599609	80	20	36.69531	412	3.899902	0.299988	0.899902	146	7.329102	124	31	null	null	4	no(M2 and SIP pres)	4
2,923	83.13794	1	female	0	10	326	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	under $11k	9	13,636	7,885.5391	6,766.62891	12	white	22.296875	46	0.738892	0.657959	1	0	1	no	0.95	0.8	no dnr	10	75	null	67	20	36.19531	null	null	null	1.399902	136	null	108	17	1,475	null	null	adl>=4 (>=5 if sur)	5.370117
2,924	93.89496	1	male	0	7	114	COPD	COPD/CHF/Cirrhosis	5	null	null	0	8,276	4,589.8164	5,258.36719	4	white	18.597656	18	0.636963	0.455994	1	0	0	yes	0.65	0.5	no dnr	7	117	7.199219	100	20	38.69531	420	4.199219	0.5	0.799927	132	7.539062	133	11	1,200	null	null	null	4.414063
2,925	63.55899	0	male	0	4	670	COPD	COPD/CHF/Cirrhosis	2	6	under $11k	0	3,814	2,211.6289	2,215.64844	9	white	14.699219	26	0.91394	0.85498	1	0	0	no	0.95	0.9	no dnr	4	113	12.099609	80	20	36.69531	null	3.599609	1.199951	1.599854	140	null	110	51	null	3	null	no(M2 and SIP pres)	2.510742
2,926	88.10699	0	male	0	11	670	CHF	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	11,812	6,656.2422	6,744.65625	11	white	21.597656	20	0.753906	0.610962	1	0	0	no	0.75	0.6	no dnr	11	123	17.898438	70	12	36.79688	160	2.199707	null	1.899902	148	7.389648	362	52	2,360	1	1	no(M2 and SIP pres)	1
2,927	88.65198	1	male	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	null	0	34,155	21,667.0938	19,497.7656	31	white	38.296875	54	0.339966	0.223999	1	1	1	no	0.2	0.1	dnr after sadm	1	107	12.398438	80	25	36.09375	272	null	0.599976	2.099609	144	7.319336	103	50	1,400	null	null	<2 mo. follow-up	6.161133
2,928	78.18195	1	female	0	13	27	Lung Cancer	Cancer	2	11	under $11k	9	11,763	7,217.9141	6,539.1875	11	white	32.5	19	0.208984	0.021	1	0	0	metastatic	0.2	0.05	dnr after sadm	1	97	7.799805	80	25	36.09375	460	null	null	1.399902	136	7.469727	184	39	1,250	null	6	<2 mo. follow-up	6
2,929	76.01398	0	male	0	7	669	COPD	COPD/CHF/Cirrhosis	2	12	$25-$50k	0	10,143	5,317.5781	5,798.20703	7	white	20.097656	19	0.806885	0.68689	1	0	0	no	null	null	no dnr	7	83	24.699219	80	15	36.09375	null	2.599609	0.699951	0.799927	134	null	148	11	982	1	null	no(M2 and SIP pres)	1.166748
2,930	91.71796	0	female	0	19	668	ARF/MOSF w/Sepsis	ARF/MOSF	4	6	under $11k	0	52,128	38,784.875	30,594.6875	26.333328	white	25.5	57	0.645996	0.544922	2	1	0	no	0.7	0.6	dnr after sadm	11	43	15.5	113	16	37.79688	154	1.899902	0.099991	0.899902	146	7.299805	186	14	1,338	null	2	adl>=4 (>=5 if sur)	2
2,931	60.78	0	male	0	14	668	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	>$50k	0	46,709	28,562.625	26,098.1562	13.333328	white	23.597656	49	0.748901	0.669922	4	0	0	yes	0.75	0.75	no dnr	14	59	10.099609	78	28	37.89844	150	3.699707	0.699951	1	142	7.459961	114	26	2,064	0	0	no(M2 and SIP pres)	0
2,932	48.87299	1	female	0	9	392	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	54,664	28,733.1094	32,420.1562	24	white	22.699219	32	0.845947	0.792969	4	0	0	no	0.98	0.98	no dnr	9	104	9.398438	108	22	36.59375	null	null	null	1.299805	140	null	133	23	2,990	0	0	no(M2 and SIP pres)	0
2,933	49.45398	0	female	0	4	664	Lung Cancer	Cancer	2	12	$25-$50k	0	12,241	6,169.6445	2,776.16992	11	white	9.199219	12	0.853882	0.67688	1	0	0	metastatic	0.8	0.5	no dnr	4	49	5.699219	107	28	38.89844	287.5	null	0.599976	1.399902	142	7.429688	110	35	2,710	0	null	no(M2 and SIP pres)	0.494751
2,934	75.33698	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	0	30,832	21,063.1719	20,832.3438	46.5	white	41.59375	57	0.333984	0.218994	1	0	0	no	0.3	0.2	dnr after sadm	2	72	15.099609	128	14	36.29688	null	2	4.099609	0.599976	131	null	164	10	1,200	null	6	<2 mo. follow-up	6
2,935	36.44897	0	female	0	6	661	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	9,396	6,253.5547	6,516.72656	12	white	26.199219	30	0.862915	0.814941	1	0	0	no	0.9	0.7	no dnr	6	60	29.796875	150	12	36.09375	66	1.699951	1.099854	0.799927	145	7.329102	309	11	965	0	null	null	0.494751
2,936	74.48297	1	male	1	31	31	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	55	53,352	38,328.8125	35,363	18.5	white	22.898438	45	0.48999	0.371948	2	0	0	yes	null	0	dnr after sadm	1	57	5	80	20	36.29688	261.875	2.799805	null	1	144	7.389648	105	9	null	null	0	<2 mo. follow-up	0
2,937	90.84998	1	female	0	8	369	CHF	COPD/CHF/Cirrhosis	5	16	$25-$50k	0	13,773	7,660.4609	7,365.83984	17	white	18	30	0.750977	0.60791	1	1	0	yes	null	null	no dnr	8	80	16.898438	80	20	36.09375	300	3.299805	1.099854	1.099854	133	7.459961	158	47	500	1	0	no(M2 and SIP pres)	0
2,938	58.70999	1	male	0	21	231	Lung Cancer	Cancer	2	null	null	0	46,753	22,374.1719	26,309.3594	14.333328	white	22.597656	20	0.598999	0.280945	1	0	0	metastatic	0.9	0.5	no dnr	21	103	6.699219	70	20	35.59375	null	null	null	2.299805	138	null	151	79	3,050	6	null	null	4.527344
2,939	79.76495	0	female	0	4	660	CHF	COPD/CHF/Cirrhosis	3	12	null	0	4,730	2,543.9805	2,328.37891	9	white	22.097656	43	0.782959	0.652954	1	1	0	no	null	null	no dnr	4	77	3.5	90	20	37.79688	290.4375	null	null	0.599976	143	7.509766	107	11	null	null	null	no(M2 and SIP pres)	2.429688
2,940	61.133	0	male	0	4	658	CHF	COPD/CHF/Cirrhosis	3	14	$11-$25k	0	4,455	2,464.0703	2,166.2793	7	white	20.898438	26	0.863892	0.773926	1	0	0	no	0.99	0.99	no dnr	4	60	16.898438	120	12	38.39844	186	null	null	1.199951	138	7.429688	196	12	1,138	0	null	no(M2 and SIP pres)	0.494751
2,941	92.28497	1	male	0	15	43	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	32,367	22,582.9531	18,268.5781	15	white	33.195313	56	0.377991	0.258972	1	0	1	yes	0.5	0.3	dnr before sadm	-1	109	9.798828	104	12	37.59375	168	1.899902	3.799805	1.099854	143	7.379883	137	25	3,430	null	1	<2 mo. follow-up	1
2,942	74.32996	0	male	0	19	657	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	$11-$25k	0	78,641	41,373.7188	39,718.4688	15	white	32.398438	52	0.602905	0.495972	1	0	0	no	0.8	0.8	no dnr	19	103	7.5	100	25	36.09375	304.75	4.299805	null	1	142	7.429688	118	21	2,575	null	0	no(M2 and SIP pres)	0
2,943	89.00195	0	male	0	9	657	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	$11-$25k	0	16,165	8,656.2188	12,441.0078	14.5	white	23.398438	28	0.7229	0.637939	1	0	0	no	0.75	0.6	no dnr	9	75	14.298828	120	22	36.59375	295.1875	2.899902	0.599976	2.399902	133	7.5	114	38	2,200	0	0	no(M2 and SIP pres)	0
2,944	74.71295	0	female	0	5	657	COPD	COPD/CHF/Cirrhosis	1	12	under $11k	0	6,499	3,311.8633	3,244.13867	12	white	19.398438	19	0.823975	0.712891	1	0	0	no	null	null	no dnr	5	46	13.398438	128	32	36.09375	216	null	null	0.699951	127	7.289062	268	19	1,610	0	null	no(M2 and SIP pres)	0.494751
2,945	83.68195	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	$11-$25k	61	16,292	12,585.8359	9,766.38281	30	white	16.296875	17	0.67395	0.578979	1	0	0	no	0.2	0.05	dnr after sadm	3	53	31.5	65	22	36.09375	98.32812	3	0.5	0.899902	140	7.469727	80	36	725	null	1	<2 mo. follow-up	1
2,946	84.71698	1	female	1	10	10	Cirrhosis	COPD/CHF/Cirrhosis	2	14	null	0	11,188	6,340.8047	6,025.9375	10	white	15.298828	30	0.714966	0.556885	1	0	0	no	0.2	0.1	no dnr	10	59	9.898438	68	25	36.09375	262.9375	null	null	1.699951	150	7.389648	131	69	1,070	null	0	<2 mo. follow-up	0
2,947	75.05499	1	female	0	7	56	COPD	COPD/CHF/Cirrhosis	3	9	under $11k	0	10,896	5,416.8984	5,122.20703	9	white	14.398438	37	0.876953	0.795898	1	0	0	no	0.9	0.6	no dnr	7	97	3.599609	56	20	36.29688	320	3.199707	null	0.899902	141	7.399414	89	26	725	2	1	<2 mo. follow-up	1
2,948	75.51294	1	male	0	6	9	Colon Cancer	Cancer	4	10	$11-$25k	0	10,102	5,214.3555	4,136.67969	12	white	32.59375	46	0.44696	0.135986	1	1	0	metastatic	0.6	0.5	dnr after sadm	3	93	9.798828	80	20	37	340	null	null	0.899902	146	7.389648	110	37	58.695312	2	1	<2 mo. follow-up	1
2,949	69.95197	0	female	0	6	651	CHF	COPD/CHF/Cirrhosis	6	12	$25-$50k	0	8,304	5,138.1016	4,948.04688	16	white	16.5	26	0.881958	0.803955	1	1	0	no	0.8	0.75	no dnr	6	70	6.199219	80	20	36.09375	383.3125	2.599609	0.699951	1.299805	148	7.439453	120	36	1,650	1	1	no(M2 and SIP pres)	1
2,950	42.198	1	male	0	4	24	ARF/MOSF w/Sepsis	ARF/MOSF	5	11	under $11k	26	8,124	5,598.8945	4,661.22656	22	other	25.199219	65	0.802979	0.737915	1	0	0	no	0.7	0.65	dnr after sadm	2	53	21.398438	125	34	38.29688	125	3	1	2.399902	152	7.439453	420	55	2,661	null	null	<2 mo. follow-up	2.992676
2,951	52.099	1	male	0	19	634	Cirrhosis	COPD/CHF/Cirrhosis	3	12	null	0	32,432	17,322.9219	15,460.4062	15	white	25.5	52	0.748901	0.603882	1	0	0	no	0.75	0.6	dnr after sadm	13	100	13.599609	100	20	36.09375	268	2.299805	null	0.899902	141	7.459961	137	15	null	1	5	no(M2 and SIP pres)	5
2,952	96.55298	1	female	0	5	448	CHF	COPD/CHF/Cirrhosis	4	9	under $11k	0	4,872	2,651.5586	2,444.11914	7	white	16.796875	19	0.793945	0.668945	1	0	0	no	0.7	0.6	dnr after sadm	1	103	18.796875	90	25	36.09375	null	null	null	1.399902	138	null	188	29	null	1	null	no(M2 and SIP pres)	1.166748
2,953	60.57999	0	male	0	6	650	ARF/MOSF w/Sepsis	ARF/MOSF	3	7	under $11k	0	17,258	12,425.8438	9,322.4375	22	white	24.199219	57	0.81897	0.758911	1	0	0	no	0.9	0.8	no dnr	6	123	5.799805	69	42	39.39844	166	2.399902	null	1.699951	149	7.459961	245	50	1,415	0	0	SIP>=30	0
2,954	77.54999	1	female	1	22	22	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	$11-$25k	0	121,358	90,567.5	66,565.25	37	white	37.5	78	0.442993	0.323975	1	0	0	no	0.5	0.5	dnr after sadm	14	121	12.798828	107	24	38.59375	null	3.399902	null	8.898438	133	null	116	106	200	null	0	<2 mo. follow-up	0
2,955	87.93994	1	female	0	8	108	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	10,547	6,321.6562	6,339.28906	6	white	26.796875	33	0.657959	0.559937	1	1	1	no	null	null	dnr before sadm	-1	123	null	121	24	35.69531	null	null	null	0.899902	141	null	161	18	2,425	null	6	null	6
2,956	80.82098	1	male	0	33	160	ARF/MOSF w/Sepsis	ARF/MOSF	4	null	null	44	66,466	41,180.625	33,514.75	22.5	black	19	35	0.60498	0.498962	2	1	1	yes	0.5	0.4	dnr after sadm	16	55	7.699219	72	35	36.89844	171.65625	null	null	0.699951	140	7.419922	112	16	1,470	null	0	adl>=4 (>=5 if sur)	0
2,957	52.405	1	male	0	15	244	MOSF w/Malig	ARF/MOSF	2	14	under $11k	0	73,204	51,713.1562	37,489.0625	24.666656	white	31	38	0.483948	0.36499	5	0	0	yes	0.1	0	no dnr	15	63	6.699219	64	20	36.59375	null	4	null	1	142	null	106	9	3,625	null	0	no(M2 and SIP pres)	0
2,958	41.202	0	female	0	32	646	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	129,721	82,183.5	56,350.5625	38	white	36.5	71	0.688965	0.595947	1	0	0	no	0.75	0.75	no dnr	32	44	21.898438	105	10	38.5	92	2.699707	null	2.599609	137	7.419922	173	55	953	null	null	null	2.36084
2,959	66.28595	1	female	0	12	43	COPD	COPD/CHF/Cirrhosis	4	12	under $11k	0	16,697	9,707.1875	10,306.0625	8.5	white	16.199219	35	0.893921	0.822998	1	0	0	no	0.75	0.5	dnr after sadm	1	47	6.5	80	20	36.09375	504.75	3	0.299988	0.799927	131	7.479492	72	3	1,200	2	1	<2 mo. follow-up	1
2,960	87.06396	1	female	0	4	70	COPD	COPD/CHF/Cirrhosis	3	8	$11-$25k	0	5,038	2,673.8769	2,827.80859	9	white	16.796875	18	0.785889	0.656982	1	0	0	no	null	null	dnr after sadm	3	100	6.799805	61	24	36.09375	159.0625	4.299805	0.299988	1.099854	133	7.299805	229	15	1,500	null	null	adl>=4 (>=5 if sur)	3.17627
2,961	29.23999	0	male	0	3	643	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	under $11k	0	5,007	2,405.1856	2,665.04883	null	white	22.5	33	0.909912	0.876953	1	0	0	no	null	null	no dnr	3	120	10.5	78	4	38.69531	151	null	null	0.899902	143	7.439453	130	21	1,730	null	null	no(M2 and SIP pres)	1.826416
2,962	62.25299	0	male	0	16	642	ARF/MOSF w/Sepsis	ARF/MOSF	4	19	null	0	47,166	34,499.5625	27,598.8594	29.666656	white	26.597656	48	0.778931	0.706909	1	1	0	no	0.5	0.5	no dnr	16	72	6.599609	80	20	36.59375	385.6875	null	null	1.599854	131	7.429688	118	40	1,730	null	3	SIP>=30	3
2,963	68.75598	0	male	0	16	642	COPD	COPD/CHF/Cirrhosis	2	12	null	0	39,370	21,827.7031	19,721.0938	18	white	14.398438	16	0.886963	0.810913	3	0	0	no	0.7	0.6	no dnr	16	78	5	92	12	35.39844	null	3.299805	0.199982	0.599976	140	null	131	5	null	1	1	no(M2 and SIP pres)	1
2,964	47.379	1	male	0	5	216	Colon Cancer	Cancer	1	null	null	0	5,139	3,095.4082	4,275.61719	11	white	15.5	14	0.862915	0.69397	1	0	0	metastatic	0.95	0.5	no dnr	5	107	12.398438	60	20	35.39844	290.4375	null	null	1.699951	142	7.369141	53	43	1,300	null	null	null	2.240723
2,965	51.64398	0	male	0	16	640	ARF/MOSF w/Sepsis	ARF/MOSF	2	18	>$50k	0	54,163	35,252	27,047.6562	35.666657	white	42.796875	103	0.379944	0.260986	1	0	0	yes	0.2	0.2	no dnr	16	83	11.298828	120	20	38.19531	null	3.699707	2.299805	1.399902	133	null	97	20	2,400	null	null	no(M2 and SIP pres)	2.358398
2,966	53.02899	1	male	0	6	36	Lung Cancer	Cancer	2	12	$11-$25k	0	10,443	5,390.8398	5,308.57812	10	black	19.699219	28	0.681885	0.386963	1	0	0	metastatic	1	0.5	no dnr	6	49	10.699219	60	10	39	220	2.099609	0.699951	4.699219	160	7.349609	150	82	2,000	0	null	<2 mo. follow-up	0.494751
2,967	90.42798	0	female	0	4	637	CHF	COPD/CHF/Cirrhosis	4	11	under $11k	0	3,956	2,251.0762	2,230.45898	8	white	17.296875	15	0.810913	0.694946	1	1	0	no	0.95	0.85	no dnr	4	111	11.099609	117	26	36.19531	127	null	null	1.899902	142	7.449219	103	58	1,480	0	null	no(M2 and SIP pres)	0.494751
2,968	76.54797	0	male	0	7	637	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	7,034	4,044.625	3,867.28906	10	white	16.597656	24	0.863892	0.774902	1	1	0	no	null	null	no dnr	7	97	6.299805	76	24	36.59375	115	4.199219	0.899902	1.5	137	7.199219	106	26	900	1	0	no(M2 and SIP pres)	0
2,969	80.75	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	$11-$25k	0	45,475	29,121.9219	26,887.3281	29	black	24.296875	41	0.661987	0.563965	16	1	0	no	0.2	0.1	dnr after sadm	1	73	7.5	100	25	36.09375	217.375	null	null	0.899902	141	7.369141	139	16	null	null	0	<2 mo. follow-up	0
2,970	49.68698	0	male	0	23	633	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$11-$25k	0	48,180	28,100.25	23,259.6562	24	white	33.898438	47	0.699951	0.609985	1	0	0	no	0.78	0.6	no dnr	23	125	13.398438	61	8	38.19531	242.5	3.599609	null	0.799927	140	7.589844	112	14	1,560	0	null	no(M2 and SIP pres)	0.494751
2,971	79.78894	0	female	0	19	632	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	under $11k	0	76,279	43,290.6875	27,250.4219	28.333328	white	16.097656	33	0.809937	0.746948	19	0	0	no	0.7	0.7	no dnr	19	100	9.099609	60	20	37	null	2.399902	0.899902	1.299805	143	null	114	16	280	null	1	no(M2 and SIP pres)	1
2,972	53.58499	0	male	0	8	632	Cirrhosis	COPD/CHF/Cirrhosis	1	16	>$50k	0	12,397	6,571.5312	5,340.19922	12.5	white	19	31	0.836914	0.733887	1	0	0	no	0.9	0.75	no dnr	8	80	4.299805	70	30	36.09375	228.5625	3.899902	1.099854	1.199951	140	7.379883	152	35	1,075	0	0	no(M2 and SIP pres)	0
2,973	91.01996	1	female	0	6	96	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	null	37	11,767	6,400.082	6,496.94922	18	white	14.699219	21	0.75293	0.674927	1	0	1	no	0.9	0.9	dnr before sadm	-1	73	7.299805	80	20	35.59375	null	2.399902	null	1.699951	132	null	351	61	1,125	null	null	SIP>=30	5.137695
2,974	74.70996	1	female	1	5	5	Coma	Coma	1	8	$11-$25k	94	18,728	13,579.5156	11,059.2188	31	white	22.5	30	0.096985	0.057999	2	0	0	yes	0	0	dnr after sadm	4	80	11.398438	80	25	36.69531	276	null	null	1	136	7.479492	227	20	2,525	null	null	<2 mo. follow-up	2.498535
2,975	59.82498	1	female	0	12	18	Colon Cancer	Cancer	4	null	null	0	15,538	8,949.1797	6,965.76953	11	null	37.695313	38	0.357971	0.077988	1	0	0	metastatic	0.5	0.25	dnr after sadm	1	53	11.898438	100	15	38.29688	null	1.799805	0.599976	7.299805	138	null	69	68	0	null	null	<2 mo. follow-up	3.479492
2,976	79.49597	0	female	0	15	629	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	null	0	37,583	23,426.4375	20,075.7812	20.333328	white	35.195313	52	0.494995	0.377991	1	0	0	no	0.5	0.5	no dnr	15	57	11.699219	80	20	36.09375	null	2.399902	7.399414	1.5	137	null	227	51	null	0	null	no(M2 and SIP pres)	0.494751
2,977	35.17599	1	male	0	18	196	MOSF w/Malig	ARF/MOSF	1	14	>$50k	0	86,623	45,066.5312	43,258.9375	21	white	27.199219	52	0.589966	0.480957	10	0	0	yes	0.4	0.2	no dnr	18	107	3	70	30	36.09375	null	null	null	0.899902	140	null	98	16	1,800	0	4	no(M2 and SIP pres)	4
2,978	66.58496	1	male	0	31	196	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	124,293	70,849.0625	67,079.6875	40	white	21.597656	42	0.833984	0.776978	1	0	0	no	0.8	0.7	no dnr	31	49	9.898438	70	16	36.09375	371.375	null	0.599976	14.5	135	7.339844	88	83	0	0	1	adl>=4 (>=5 if sur)	1
2,979	86.10797	0	male	0	13	625	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	26,338	17,204.7031	14,160.6172	27	white	32.398438	40	0.482971	0.36499	3	0	0	no	0.95	0.85	dnr after sadm	1	111	27.199219	119	10	36	66	2.299805	0.599976	7.199219	135	7.489258	184	79	345	0	1	no(M2 and SIP pres)	1
2,980	75.44696	0	female	0	32	622	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	null	0	87,543	62,266.3438	51,062.6562	33	white	32.695313	46	0.586914	0.477966	1	0	1	no	0.5	0.5	dnr after sadm	4	50	6.099609	60	20	35.59375	null	null	null	1.399902	136	null	145	42	null	null	null	null	3.80957
2,981	89.09198	0	male	0	7	623	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	14,379	9,627.0469	8,098.1875	8.5	black	21.597656	34	0.699951	0.609985	1	0	0	yes	0.9	0.9	no dnr	7	109	12.398438	72	4	38.79688	295	2.199707	null	1.299805	139	7.429688	274	19	2,160	null	null	null	3.843262
2,982	85.70795	0	male	0	18	623	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	$25-$50k	0	55,561	31,941	39,482.3125	33.666657	white	18.597656	36	0.813965	0.751953	1	0	0	no	0.7	0.7	no dnr	18	113	13.199219	110	10	36.09375	91.42188	2.099609	null	0.599976	137	7.429688	180	20	8,550	null	5	adl>=4 (>=5 if sur)	5
2,983	77.23798	1	male	1	29	29	MOSF w/Malig	ARF/MOSF	3	15	$11-$25k	0	84,604	49,319.5625	46,697.875	17	hispanic	18.597656	29	0.724976	0.640991	8	0	0	yes	0.8	0.1	dnr after sadm	1	51	2.599609	155	10	38.19531	125	1.599854	1	0.799927	143	7.259766	73	21	2,640	2	1	<2 mo. follow-up	1
2,984	49.875	1	male	0	16	235	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	57,210	34,996.625	32,341.1406	30.666656	white	23.097656	34	0.871948	0.786987	1	0	0	no	0.7	0.7	no dnr	16	73	9.298828	70	25	36.69531	260	null	null	0.799927	141	7.359375	213	27	600	null	0	SIP>=30	0
2,985	88.487	1	female	0	6	498	CHF	COPD/CHF/Cirrhosis	2	13	under $11k	0	5,350	3,153.6074	3,773.96875	15	white	20.097656	19	0.776978	0.643921	1	0	0	no	0.95	0.6	no dnr	6	73	11.099609	70	20	36.09375	678.25	null	null	1.199951	142	7.279297	155	38	null	2	null	no(M2 and SIP pres)	1.838867
2,986	63.064	0	male	0	20	618	COPD	COPD/CHF/Cirrhosis	2	16	$25-$50k	0	44,135	30,358.0156	26,456.7188	22.666656	white	23.398438	24	0.834961	0.730957	1	0	0	no	0.9	0.7	dnr after sadm	1	57	14.599609	124	10	39.09375	368.3125	4.399414	0.5	1	136	7.5	137	11	null	null	0	SIP>=30	0
2,987	77.84296	0	male	0	10	618	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	16,510	11,070.5391	10,050.3594	20	white	29	45	0.662964	0.564941	1	1	0	no	0.9	0.8	no dnr	10	67	7.5	73	12	36.29688	152	3.099609	0.399963	5.599609	131	7.389648	317	146	2,745	0	0	no(M2 and SIP pres)	0
2,988	35.13998	1	female	1	8	8	MOSF w/Malig	ARF/MOSF	1	15	>$50k	0	134,773	77,402.1875	58,795.5	45.5	white	37.695313	77	0.266968	0.159973	22	0	0	yes	0.5	0.4	dnr after sadm	7	118	8.898438	68	24	39	366.625	null	null	1.399902	140	7.459961	96	26	2,100	null	1	<2 mo. follow-up	1
2,989	77.862	1	female	0	17	448	ARF/MOSF w/Sepsis	ARF/MOSF	3	15	$11-$25k	0	50,395	29,363.4375	26,245.6719	23.333328	white	28.597656	35	0.600952	0.493958	1	1	0	yes	0.8	0.65	no dnr	17	69	6.299805	72	20	35.79688	null	null	0.5	1.199951	142	null	106	14	2,875	null	0	no(M2 and SIP pres)	0
2,990	79.59198	0	female	0	24	615	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	0	81,465	45,749.0625	43,473.0938	39	white	30.199219	54	0.573975	0.462952	4	0	0	no	0.8	0.8	no dnr	24	111	0.399963	170	28	36.19531	135	2.299805	2.099609	7.799805	135	7.349609	90	103	1,660	null	3	no(M2 and SIP pres)	3
2,991	66.10297	1	female	0	3	204	COPD	COPD/CHF/Cirrhosis	4	12	$11-$25k	0	7,201	5,917.7344	4,878.83984	null	black	18.898438	46	0.870972	0.785889	1	1	0	no	0.8	0.7	no dnr	3	87	7.099609	80	20	36.69531	null	null	0.399963	3.5	142	null	88	70	1,375	0	null	no(M2 and SIP pres)	0.494751
2,992	53.55499	0	female	0	21	614	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	>$50k	0	65,863	47,683.4688	36,288.7188	34	white	23.699219	35	0.845947	0.792969	1	1	0	no	0.9	0.9	no dnr	21	97	7.799805	70	25	36.09375	null	null	null	0.799927	139	null	162	13	1,600	null	1	SIP>=30	1
2,993	61.952	1	female	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	44	42,843	32,285.8125	26,218.7344	22.333328	null	25.898438	60	0.642944	0.541992	1	0	0	no	0.05	0	dnr after sadm	8	70	3.799805	80	20	35.59375	null	3.899902	null	1.799805	137	null	112	33	null	null	null	<2 mo. follow-up	2.327637
2,994	84.57794	0	male	0	13	613	CHF	COPD/CHF/Cirrhosis	2	22	null	0	14,980	8,515	7,564.96875	10.5	white	22.699219	31	0.750977	0.606934	1	0	0	no	0.8	0.5	no dnr	13	63	30.097656	75	24	36.19531	null	2.5	null	5.099609	134	null	303	300	2,155	1	4	SIP>=30	4
2,995	81.06494	1	male	0	6	36	CHF	COPD/CHF/Cirrhosis	4	12	>$50k	0	5,775	3,203.0195	3,340.48828	17	white	19.5	17	0.815918	0.701904	1	0	0	no	0.85	0.8	no dnr	6	111	13	110	34	39.59375	162	null	null	1.5	135	7.439453	158	37	3,650	0	null	<2 mo. follow-up	0.494751
2,996	58.168	1	female	0	5	347	CHF	COPD/CHF/Cirrhosis	5	12	null	0	6,601	3,433.3731	2,950.85938	18	black	18.898438	35	0.860962	0.770996	1	1	0	yes	0.85	0.85	no dnr	5	110	5.699219	44	34	36.19531	79	2.599609	0.699951	1.899902	138	7.359375	132	27	1,675	1	null	no(M2 and SIP pres)	1.166748
2,997	71.64398	1	male	0	17	48	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	>$50k	0	49,989	27,934.75	27,841.6719	24	white	29.597656	37	0.572998	0.461975	3	0	0	yes	0.9	0.7	no dnr	17	56	10.5	70	6	37.79688	232.5	2	0.199982	1.199951	143	7.479492	152	21	3,200	null	null	<2 mo. follow-up	2.953613
2,998	63.76999	1	male	0	18	548	ARF/MOSF w/Sepsis	ARF/MOSF	0	22	>$50k	0	69,599	35,332.0312	44,057.0312	22.333328	white	17.398438	33	0.884888	0.843994	1	0	0	no	0.9	0.9	no dnr	18	83	6	80	20	38.29688	null	3	4.5	1.699951	133	null	95	39	800	0	0	no(M2 and SIP pres)	0
2,999	58.60397	1	male	0	37	563	MOSF w/Malig	ARF/MOSF	5	22	$25-$50k	0	141,401	91,900.25	73,641.5625	35.25	white	35.898438	48	0.353943	0.237	3	0	0	yes	0.6	0.5	no dnr	37	112	8.398438	76	22	36	null	null	null	1.199951	137	null	93	25	1,325	null	1	adl>=4 (>=5 if sur)	1
3,000	44.49597	1	female	0	6	16	Lung Cancer	Cancer	2	12	$25-$50k	0	5,962	3,463.832	4,775.07812	6	black	29.597656	50	0.455994	0.142975	1	0	0	metastatic	0.15	0.01	dnr after sadm	2	116	16.796875	118	32	39.09375	250	4	null	0.799927	145	7.40918	315	18	887	null	null	<2 mo. follow-up	2.540527

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.